Nicholas A. Vitanza

4.1k total citations
63 papers, 1.1k citations indexed

About

Nicholas A. Vitanza is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Nicholas A. Vitanza has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 31 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Nicholas A. Vitanza's work include Glioma Diagnosis and Treatment (36 papers), CAR-T cell therapy research (26 papers) and Neuroblastoma Research and Treatments (12 papers). Nicholas A. Vitanza is often cited by papers focused on Glioma Diagnosis and Treatment (36 papers), CAR-T cell therapy research (26 papers) and Neuroblastoma Research and Treatments (12 papers). Nicholas A. Vitanza collaborates with scholars based in United States, Australia and Switzerland. Nicholas A. Vitanza's co-authors include Michelle Monje, Courtney A. Crane, Nicole A. P. Lieberman, Tomek Swigut, Joanna Wysocka, Surya Nagaraja, Esther Hulleman, Yujie Tang, Meng Li and Wei Meng and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Cell.

In The Last Decade

Nicholas A. Vitanza

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas A. Vitanza United States 16 590 443 319 236 145 63 1.1k
Eugene Hwang United States 19 635 1.1× 398 0.9× 323 1.0× 386 1.6× 230 1.6× 57 1.2k
Francesco Di Meco Italy 14 348 0.6× 312 0.7× 245 0.8× 113 0.5× 136 0.9× 40 929
Robert Cavaliere United States 17 529 0.9× 247 0.6× 430 1.3× 196 0.8× 112 0.8× 53 1.1k
Carl Koschmann United States 18 530 0.9× 428 1.0× 181 0.6× 188 0.8× 120 0.8× 79 935
Asadullah Khan Pakistan 7 568 1.0× 418 0.9× 356 1.1× 120 0.5× 83 0.6× 37 1.2k
David Tran United States 20 568 1.0× 528 1.2× 485 1.5× 105 0.4× 167 1.2× 39 1.4k
Tiffany R. Hodges United States 19 722 1.2× 316 0.7× 280 0.9× 188 0.8× 184 1.3× 43 1.5k
Sergey Popov United Kingdom 20 358 0.6× 825 1.9× 316 1.0× 169 0.7× 177 1.2× 48 1.5k
Ryusuke Hatae Japan 17 554 0.9× 295 0.7× 216 0.7× 147 0.6× 137 0.9× 56 979
Benjamin Himes United States 15 310 0.5× 411 0.9× 188 0.6× 138 0.6× 206 1.4× 36 932

Countries citing papers authored by Nicholas A. Vitanza

Since Specialization
Citations

This map shows the geographic impact of Nicholas A. Vitanza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas A. Vitanza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas A. Vitanza more than expected).

Fields of papers citing papers by Nicholas A. Vitanza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas A. Vitanza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas A. Vitanza. The network helps show where Nicholas A. Vitanza may publish in the future.

Co-authorship network of co-authors of Nicholas A. Vitanza

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas A. Vitanza. A scholar is included among the top collaborators of Nicholas A. Vitanza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas A. Vitanza. Nicholas A. Vitanza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foster, Jessica, Peter J. Madsen, Nikhil Joshi, et al.. (2025). Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high-grade glioma models. Neuro-Oncology. 27(10). 2684–2696. 1 indexed citations
2.
Li, Lucy Z., Matthew D. Dun, Jessica Foster, et al.. (2025). Engineered CXCR3-A expression enhances B7-H3-targeting CAR T cell migration and efficacy against diffuse intrinsic pontine glioma. Nature Communications. 16(1). 9914–9914.
3.
Pinto, Navin, Catherine M. Albert, Mallory Taylor, et al.. (2024). STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors. Journal of Clinical Oncology. 42(35). 4163–4172. 14 indexed citations
4.
Ronsley, Rebecca, et al.. (2024). CAR T cell therapy for pediatric central nervous system tumors: a review of the literature and current North American trials. Cancer and Metastasis Reviews. 43(4). 1205–1216. 3 indexed citations
5.
Crotty, Erin, Vera Paulson, Rebecca Ronsley, et al.. (2024). Cerebrospinal fluid liquid biopsy by low-pass whole genome sequencing for clinical disease monitoring in pediatric embryonal tumors. Neuro-Oncology Advances. 6(1). 2 indexed citations
6.
Madsen, Peter J., Tiffany Smith, Nicholas A. Vitanza, et al.. (2023). Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice. Journal of Visualized Experiments. 4 indexed citations
7.
Strachan, Mark W. J., Jayne Vogelzang, Keith L. Ligon, et al.. (2023). P11.84.A PHASE 1 TRIAL OF MARIZOMIB ALONE AND IN COMBINATION WITH PANOBINOSTAT IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG). Neuro-Oncology. 25(Supplement_2). ii95–ii96. 1 indexed citations
8.
Bonda, David, Sarah Leary, Nicholas A. Vitanza, et al.. (2023). A Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors. Pediatric Neurosurgery. 58(3). 150–159. 5 indexed citations
9.
Foster, Jessica, Marta M. Alonso, Elias Sayour, et al.. (2023). Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology. Neoplasia. 42. 100909–100909. 8 indexed citations
10.
Levy, Shiri, Ashish Phal, Sven Schmidt, et al.. (2022). dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region. Cell Reports. 38(9). 110457–110457. 14 indexed citations
11.
Zhang, Michael, Lydia Tam, Jason N. Wright, et al.. (2022). Radiomics Can Distinguish Pediatric Supratentorial Embryonal Tumors, High-Grade Gliomas, and Ependymomas. American Journal of Neuroradiology. 43(4). 603–610. 13 indexed citations
12.
Zhang, Michael, Michelle Han, Alireza Radmanesh, et al.. (2021). Radiomic Phenotypes Distinguish Atypical Teratoid/Rhabdoid Tumors from Medulloblastoma. American Journal of Neuroradiology. 42(9). 1702–1708. 14 indexed citations
13.
Sarthy, Jay F., Michael P. Meers, Derek H. Janssens, et al.. (2020). Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones. eLife. 9. 46 indexed citations
14.
Przystal, Justyna M., Sridevi Yadavilli, Viveka Nand Yadav, et al.. (2020). DIPG-64. INTERNATIONAL PRECLINICAL DRUG DISCOVERY AND BIOMARKER PROGRAM INFORMING AN ADOPTIVE COMBINATORIAL TRIAL FOR DIFFUSE MIDLINE GLIOMAS. Neuro-Oncology. 22(Supplement_3). iii300–iii300. 1 indexed citations
15.
Perez, Francisco A., et al.. (2020). NFB-13. TRAMETINIB FOR PLEXIFORM NEUROFIBROMA AND RECURRENT LOW-GRADE GLIOMA. Neuro-Oncology. 22(Supplement_3). iii420–iii420. 1 indexed citations
16.
Steineck, Angela, Niklas Krumm, Jay F. Sarthy, et al.. (2019). Response to Pembrolizumab in a Patient With Xeroderma Pigmentosum and Advanced Squamous Cell Carcinoma. JCO Precision Oncology. 3(3). 1–6. 9 indexed citations
17.
Iv, Michael, Mu Zhou, Katie Shpanskaya, et al.. (2018). MR Imaging–Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma. American Journal of Neuroradiology. 40(1). 154–161. 81 indexed citations
18.
Nagaraja, Surya, Nicholas A. Vitanza, Pamelyn J. Woo, et al.. (2017). Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma. Cancer Cell. 31(5). 635–652.e6. 257 indexed citations
19.
Bhatla, Teena, Courtney L. Jones, Julia A. Meyer, et al.. (2014). The Biology of Relapsed Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 36(6). 413–418. 31 indexed citations
20.
Vitanza, Nicholas A., Laura Hogan, Guangxiang Zhang, & Robert I. Parker. (2014). The Progression of Bone Mineral Density Abnormalities After Chemotherapy for Childhood Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 37(5). 356–361. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugene Hwang Breakdown of academic impact, for papers by Francesco Di Meco Breakdown of academic impact, for papers by Robert Cavaliere Breakdown of academic impact, for papers by Carl Koschmann Breakdown of academic impact, for papers by Asadullah Khan Breakdown of academic impact, for papers by David Tran Breakdown of academic impact, for papers by Tiffany R. Hodges Breakdown of academic impact, for papers by Sergey Popov Breakdown of academic impact, for papers by Ryusuke Hatae Breakdown of academic impact, for papers by Benjamin Himes
Rankless by CCL
2026